Nature of Disclosure: Regulatory filing pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the allotment of equity shares under an Employee Stock Option Plan (ESOP).
Key Event: The Nomination and Remuneration Committee (NRC) of the Board of Directors approved the allotment of 54,728 equity shares of face value ₹1 each to eligible employees upon exercise of options vested under the Dr. Agarwal's Health Care Limited – Employees Stock Option Scheme 2022.
Committee Meeting Details:
- Date: Thursday, November 05, 2026
- Commencement Time: 04:30 P.M. IST
- Conclusion Time: 04:45 P.M. IST
Capital Structure Impact:
- Pre-allotment paid-up equity share capital: ₹31,70,44,383 (31,70,44,383 equity shares)
- Post-allotment paid-up equity share capital: ₹31,70,99,111 (31,70,99,111 equity shares)
- Increase in share capital: ₹54,728
Share Allotment Details:
- Date of Issue: November 05, 2026
- Number of Shares Issued: 54,728 equity shares
- Par Value: ₹1 per share
- Distinctive Numbers: 31,70,44,384 to 31,70,99,111
- Share Certificate: Not Applicable (demat)
Exercise Price and Premium Details:
The shares were allotted at three different price points corresponding to different tranches of options:
- 4,528 shares at an exercise price of ₹84.93 each (Premium: ₹83.93 per share)
- 9,700 shares at an exercise price of ₹129.88 each (Premium: ₹128.88 per share)
- 40,500 shares at an exercise price of ₹409.08 each (Premium: ₹408.08 per share)
Additional Information:
- The newly allotted shares are identical in all respects and rank pari passu with existing equity shares.
- No lock-in restrictions apply to these shares.
- No listing fees are payable for this issuance.
- The scheme was originally filed with stock exchanges on February 24, 2025 (BSE Filing No: 224564, NSE Filing No: NSE/LIST/47322).
Company Information:
- Listed on: BSE Limited and National Stock Exchange of India Limited